Severity: Warning
Message: fopen(/var/lib/php/sessions/ci_sessionpr2antdnqrjm7uv48epdj4jmmvg91d90): Failed to open stream: No space left on device
Filename: drivers/Session_files_driver.php
Line Number: 177
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
Severity: Warning
Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)
Filename: Session/Session.php
Line Number: 137
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
218 results match your criteria: "From the Mayo Clinic[Affiliation]"
Neurology
January 2025
From the Mayo Clinic, Rochester, MN.
Dermatitis
December 2024
Department of Dermatology, Mayo Clinic, Jacksonville, Florida, USA.
It is generally recommended that patients not be on immunosuppressive medications for patch testing, as these medications may suppress delayed-type hypersensitivity and lead to false negative results. There is a paucity of literature describing organ transplant recipients who underwent patch testing. The aim of this study is to examine patch testing results in solid organ transplant recipients over a 13-year period at our institution.
View Article and Find Full Text PDFJ ECT
November 2024
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN.
Objectives: Electroconvulsive therapy (ECT) is considered to be the most effective treatment for severe depression. This study investigated recent ECT outcomes for depression at a large tertiary center, which also provides community care.
Methods: Data were obtained from Mayo Clinic Rochester patients ages 18 and older who received an acute course of ECT between August 1, 2017 and April 30, 2024.
J ECT
November 2024
Department of Psychiatry and Psychology.
Objective: To describe the immediate clinical outcomes of repetitive transcranial magnetic stimulation (rTMS) in treating long COVID symptoms. Long COVID currently impacts approximately 5.3% of US adults, presenting with persistent fatigue, depression, anxiety, cognitive impairments, and social function decline.
View Article and Find Full Text PDFClin Nucl Med
December 2024
Division of Nuclear Medicine, Mayo Clinic Arizona, Phoenix, AZ.
Trigeminal neuralgia (TN) is characterized by excruciating facial pain usually caused by neurovascular compression of the trigeminal nerve roots. TN can be treated medically or invasively. Microvascular decompression is the procedure of choice and usually results in complete symptom relief.
View Article and Find Full Text PDFAnesth Analg
January 2025
Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota.
Background: Sugammadex, aprepitant, and fosaprepitant are increasingly used perioperatively. These medications may interfere with the effectiveness of hormonal contraception. This study assessed anesthesia providers' use of sugammadex and aprepitant, their knowledge of interactions with hormonal birth control, and patient counseling practices to identify possible knowledge gaps or opportunities for practice improvement.
View Article and Find Full Text PDFAbstractMorning Report is a time-honored tradition where physicians-in-training present cases to their colleagues and clinical experts to collaboratively examine an interesting patient presentation. The Morning Report section seeks to carry on this tradition by presenting a patient's chief concern and story, inviting the reader to develop a differential diagnosis and discover the diagnosis alongside the authors of the case. This report examines the story of a 59-year-old man who initially had a sore throat, a truncal rash, and fever.
View Article and Find Full Text PDFAnn Surg Open
September 2024
Division of Urology, Department of Surgery, University of Toronto, Toronto, ON, Canada.
Neurology
October 2024
From the Mayo Clinic, Rochester, MN.
Radiology
September 2024
From the Mayo Clinic Rochester, 200 1st Street SW, Rochester, MN 55905 (W.V.B., T.L.B., Z.K., C.C., P.I.C.A.); Cleveland Clinic, Cleveland, Ohio (M.F., C.K., M.P.); Massachusetts General Hospital, Harvard Medical School, Boston, Mass (A.S.S.B., A.K.); University of Michigan, Ann Arbor, Mich (M.D.S.); Mayo Clinic Arizona, Phoenix, Ariz (S.Y., M.Y.); Chamie Imagem da Mulher, São Paulo, Brazil (L.P.C.); University of California San Francisco, San Francisco, Calif (L.G., J.T.R., L.P.); NYU Grossman School of Medicine, New York, NY (N.M.H., A.T., M.T.T.); David Geffen School of Medicine, Los Angeles, Calif (H.D.D.); University of Arizona College of Medicine Phoenix/Banner University Medical Center-Phoenix (R.M.K.); Stanford University School of Medicine, Stanford, Calif (L.S.); Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (K.S.B.); Clinic Izabela Pires Franco, Belém, Brazil (I.V.P.F.); Temerty Faculty of Medicine (P.G.), University of Toronto, Toronto, Ontario, Canada (A.Z.K.); Thomas Jefferson University Hospital, Philadelphia, Pa (L.M.K.); University of Texas Health Science Center at San Antonio, San Antonio, Tex (A.B.); University of Arizona College of Medicine, Banner University Medicine, Tucson, Ariz (H.A.T.); Columbia University Irving Medical Center, New York, NY (S.L.N.); SUNY Upstate Medical University, Syracuse, NY (R.N.); and Department of Radiology, Stanford University School of Medicine, Stanford, Calif (P.J.).
Neurology
October 2024
From the Mayo Clinic Alix School of Medicine (L.R.), and Departments of Internal Medicine (L.G.), and Neurology (R.M.), Mayo Clinic, Rochester, MN.
N Engl J Med
July 2024
From the Mayo Clinic, Rochester, MN (M.R.L., C.L.W., M.A.E.); Dana-Farber Cancer Institute, Boston (Z.S., D.J.D., R.M.S.); the University of Wisconsin Carbone Cancer Center, Madison (R.J.M.), and the Medical College of Wisconsin, Milwaukee (E.L.A.); Montefiore Medical Center Moses Campus (E.M.P., J.R.) and Memorial Sloan Kettering Cancer Center (Y. Zhang, M.S.T.) - both in New York; the Department of Pathology and the Center for Excellence for Leukemia Studies (K.G.R., Y. Zhao, C.G.M.) and the Center for Applied Bioinformatics (G.W., T.-C.C., W.Z.), St. Jude's Children's Research Hospital, Memphis, TN; Case Western Reserve University (H.M.L.) and Cleveland Clinic Foundation (A.S.A.), Cleveland, and the Ohio State University Comprehensive Cancer Center, Columbus (B.B.) - all in Ohio; Shaare Zedek Medical Center, Jerusalem, Israel (J.M.R.); Stanford Cancer Institute, Palo Alto (D.A.A., M.L.), the University of California, San Diego, Moores Cancer Center, La Jolla (M.J.W., D.T.), and the University of California, Irvine, Health Cancer Center-Newport, Orange (D.J.) - all in California; the University of Chicago (D.A.A.) and Northwestern University (S.N.D.) - both in Chicago; Hopital Maisonneuve-Rosemont, Montreal (J.B.); the University of Washington, Seattle (B.L.W.); Johns Hopkins University Sidney Kimmel Cancer Center, Baltimore (K.W.P.), and the National Cancer Institute, National Institutes of Health, Bethesda (E.S., R.F.L.) - both in Maryland; the University of Pennsylvania Abramson Cancer Center, Philadelphia (N.F., S.M.L.); Yale School of Medicine, New Haven, CT (S.D.G.); the Washington University in St. Louis School of Medicine, St. Louis (G.L.U.); the University of Kansas Cancer Center, Westwood (T.L.L.); Virginia Commonwealth University Massey Cancer Center, Richmond (S.B.P.); the University of Alabama at Birmingham, Birmingham (P.V.); and Wake Forest University Health Sciences, Winston-Salem (R.R.B.), and Duke University Medical Center, Durham (H.P.E.) - both in North Carolina.
Background: Many older adults with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) have a relapse despite having a measurable residual disease (MRD)-negative complete remission with combination chemotherapy. The addition of blinatumomab, a bispecific T-cell engager molecule that is approved for the treatment of relapsed, refractory, and MRD-positive BCP-ALL, may have efficacy in patients with MRD-negative remission.
Methods: In a phase 3 trial, we randomly assigned patients 30 to 70 years of age with -negative BCP-ALL (with :: indicating fusion) who had MRD-negative remission (defined as <0.
Cutis
May 2024
Dane J. Markham is from the Mayo Clinic Alix School of Medicine, Jacksonville, Florida. Taylor S. Davis is from the Saint Louis University School of Medicine, Missouri. Max E. Oscherwitz is from the Heersink School of Medicine, University of Alabama, Birmingham. Dr. Jorizzo is from the Department of Dermatology, Wake Forest University, Winston-Salem, North Carolina.
Orodynia (OD) manifests as an unexplained burning sensation in the oral cavity, often persisting for years without clear clinical findings. Currently, there is no clear protocol for managing OD. We propose a systematic approach that aims to exclude common potential causes and attempt proactive treatments.
View Article and Find Full Text PDFJ Trauma Acute Care Surg
August 2024
From the Mayo Clinic Alix School of Medicine (R.T.R.); Department of Anesthesiology and Perioperative Medicine (K.L.W., W.W.P., E.K.G., M.J.J., T.B.C., C.C.W.), and Department of Physiology and Biomedical Engineering (D.R.H., C.R.H.), Mayo Clinic, Rochester, Minnesota; Department of Kinesiology (C.C.W.), Michigan State; East Lansing, Michigan; and Battlefield Health and Trauma Center for Human Integrative Physiology (V.A.C.), US Army Institute of Surgical Research, JBSA Fort Sam Houston, San Antonio, Texas.
Background: The Compensatory Reserve Metric (CRM) provides a time sensitive indicator of hemodynamic decompensation. However, its in-field utility is limited because of the size and cost-intensive nature of standard vital sign monitors or photoplethysmographic volume-clamp (PPG VC ) devices used to measure arterial waveforms. In this regard, photoplethysmographic measurements obtained from pulse oximetry may serve as a useful, portable alternative.
View Article and Find Full Text PDFRadiographics
May 2024
From the Mayo Clinic Artificial Intelligence Laboratory and Radiology Informatics Laboratory, Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905.
Am J Phys Med Rehabil
November 2024
From the Mayo Clinic Alix School of Medicine (RAC), Mayo Clinic, Rochester, Minnesota; Department of Physical Medicine & Rehabilitation, Mayo Clinic, Rochester, Minnesota (MJW, RKR, MTL), and Department of Anesthesia and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota (NCC).
AJNR Am J Neuroradiol
April 2024
Mayo Clinic (P.A., P.M., I.T.M., S.A.M., G.B.), Rochester, Minnesota.
High-grade astrocytoma with piloid features (HGAP) is a recently identified brain tumor characterized by a distinct DNA methylation profile. Predominantly located in the posterior fossa of adults, HGAP is notably prevalent in individuals with neurofibromatosis type 1. We present an image-centric review of HGAP and explore the association between HGAP and neurofibromatosis type 1.
View Article and Find Full Text PDFExp Clin Transplant
January 2024
From the Mayo Clinic, Phoenix, Arizona, USA.
Transplant surgery has undergone significant advancements with the emergence of minimally invasive techniques, particularly in kidney and liver transplantation. This review explores the applications and impact of minimally invasive approaches in transplant surgeries. The history of laparoscopy and robotic surgery is discussed, highlighting the evolution of these techniques and their contributions to the field of minimally invasive surgery.
View Article and Find Full Text PDF